NEWS: 公告在東京證券交易所JASDAQ標準市場新上市

表紙
市場調查報告書

歐洲的到轉染市場:至2028年的產業趨勢與預測

Europe Transfection Market - Industry Trends and Forecast to 2028

出版商 Data Bridge Market Research Private Limited 商品編碼 977683
出版日期 內容資訊 英文 150 Pages
商品交期: 3-5個工作天內
價格
歐洲的到轉染市場:至2028年的產業趨勢與預測 Europe Transfection Market - Industry Trends and Forecast to 2028
出版日期: 2020年11月01日內容資訊: 英文 150 Pages
簡介

歐洲的轉染市場,預計從2021年到2028年的預測期間以8.96%的年複合成長率順利成長。該市場的主要的成長要素,是合成生物學產品開發,市場企業的策略性舉措等。

本報告提供歐洲的轉染市場的相關調查,市場規模和預測,機會和課題,成長及阻礙因素,各類型、手法、產品、生物、分子類型、用途、階段、終端用戶、流通管道、地區的市場分析,競爭情形,主要企業的簡介等資訊。

目錄

第1章 簡介

第2章 市場區隔

第3章 摘要整理

第4章 重要考察

  • 整體潛在市場
    • 各方法/模式
    • 各終端用戶
    • 各用途
    • 各階段
  • 生物醫藥品的初期及後期階段的細胞株開發及基因治療的病毒載體生產
    • 用中國倉鼠卵巢(CHO)細胞生產的已通過核准抗體清單及哺乳類的表現媒介使用的可選擇的標記清單

第5章 法律規範

  • 歐洲聯盟的法規方案
  • 美國的法規方案
  • 日本的法規方案
  • 中國的法規方案

第6章 市場概要

  • 成長要素
    • 慢性疾病的盛行率上升
    • 合成生物學產品的開發
    • 嵌合遺傳基因的需求高漲
    • 臨床研究所使用的大規模轉染
    • 蛋白質的產生的生物醫藥品的使用
  • 阻礙因素
    • 轉染產品的成本高
    • 轉染試劑的選擇中有效性
    • 轉染程序引起的細胞損傷
  • 市場機會
    • 新興市場開拓
    • 市場參與者的策略性舉措
    • 政府的輔助增加
    • 投資等級劇增
  • 課題
    • 長期批審
    • 缺乏病毒相關轉染用安全等級的實驗室
    • 受訓練的專家不足

第7章 COVID-19的影響

  • 概要
  • 對價格的影響
  • 對需求的影響
  • 對供應鏈的影響
  • 製造商的策略性舉措
  • 結論

第8章 市場分析:各類型

  • 概要
  • 一時性轉染
  • 穩定轉染

第9章 市場分析:各手法

  • 概要
  • 非病毒
    • 化學性
    • 物理性
  • 病毒
    • 反轉錄病毒轉染
    • 腺病毒轉染
    • 慢病毒轉染
    • 其他

第10章 市場分析:各產品

  • 概要
  • 試劑和套件
    • 陽離子性脂質
    • 陽離子聚合物
    • 奈米粒子
    • 套件
    • CUVETTE CHAMBER
    • 其他
  • 設備
    • 電穿孔系統
    • 電力細胞融合發電機
    • 動電學的轉染系統
    • HEPTA系統
    • 管材準備站
    • RT-PCR
    • 槍系統
    • 微量盤式分析儀
    • Sonoporation系統
    • 顯微鏡
    • 其他

第11章 市場分析:各生物

  • 概要
  • 哺乳類的細胞
  • 植物
  • 菌類
  • 病毒
  • 細菌

第12章 市場分析:各分子類型

  • 概要
  • 質體DNA
  • 低分子干涉RNA(SIRNA)
  • 蛋白質
  • DNA寡核苷酸
  • 核糖核蛋白質複合體(RNPS)
  • 其他

第13章 市場分析:各用途

  • 概要
  • 各類型
    • in vitro
    • in vivo
    • 生物產品
    • 其他
  • 各業界
    • 合成生物學
    • 農業
    • 其他

第14章 市場分析:各階段

  • 概要
  • 調查
  • 前臨床
  • 臨床階段
  • 商業

第15章 市場分析:各終端用戶

  • 概要
  • 生物醫藥品
  • 委託調查機關(CROS)
  • 契約製造組織/契約開發及製造組織(CMOS/CDMOS)
  • 學術機構
  • 醫院
  • 臨床實驗室
  • 其他

第16章 市場分析:各流通管道

  • 概要
  • 直接競標
  • 零售
  • 其他

第17章 市場分析:各地區

  • 歐洲
    • 德國
    • 法國
    • 義大利
    • 英國
    • 西班牙
    • 瑞士
    • 俄羅斯
    • 荷蘭
    • 比利時
    • 土耳其
    • 其他歐洲

第18章 競爭情形

  • 企業佔有率分析:歐洲

第19章 SWOT分析

第20章 企業簡介

  • THERMOFISHER SCIENTIFIC INC.
  • ROCHE MOLECULAR SYSTEMS, INC. (A SUBSIDIARY OF F. HOFFMANN-LA ROCHE LTD)
  • QIAGEN
  • PROMEGA CORPORATION
  • TAKARA BIO INC.
  • BIO-RAD LABORATORIES, INC.
  • LONZA
  • CYTIVA
  • ALTOGEN BIOSYSTEMS
  • AMYRIS
  • APPLIED BIOLOGICAL MATERIALS INC. (ABM)
  • AUTOLUS
  • AVANTI POLAR LIPIDS (A SUBSIDIARY OF CRODA INTERNATIONAL PLC)
  • BECKMAN COULTER, INC. (A SUBSIDIARY OF DANAHER)
  • CODEXIS
  • CONAGEN, INC.
  • FUJIFILM IRVINE SCIENTIFIC (A SUBSIDIARY OF FUJIFILM HOLDINGS CORPORATION)
  • GENLANTIS INC.
  • GENO TECHNOLOGY INC., USA
  • GINKGO BIOWORKS
  • IMPOSSIBLE FOODS INC
  • MAXCYTE, INC.
  • MERCK KGAA
  • MIRUS BIO LLC.
  • ORIGENE TECHNOLOGIES, INC.
  • PERKINELMER CHEMAGEN TECHNOLOGIE GMBH (A SUBSIDIARY OF PERKINELMER INC.)
  • POLYPLUS TRANSFECTION
  • POSEIDA THERAPEUTICS, INC.
  • R&D SYSTEMS, INC.
  • SBS GENETECH
  • SIGNAGEN LABORATORIES
  • TWIST BIOSCIENCE
  • VERVE THERAPEUTICS, INC.
  • ZYMERGEN INC.

第21章 問卷調查

第22章 相關報告

目錄

Europe transfection market is projected to register a healthy CAGR of 8.96% in the forecast period of 2021 to 2028. The new market report contains data for the historic year 2019, the base year of calculation is 2020 and the forecast period is 2021 to 2028.

Market Segmentation

Europe Transfection Market, Type (Transient Transfection and Stable Transfection), Methods (Non-Viral Methods and Viral Methods), CRISPR Transfection Methods (Non-Viral Methods and Viral Methods), Products (Reagents & Kits, Instrument and Software), Organism (Mammalian Cells, Plants, Fungi, Virus and Bacteria), Types of Molecule (Plasmid DNA, Small Interfering RNA (siRNA), Proteins, DNA Oligonucleotides, Ribonucleoprotein Complexes (RNPs) and Others), Application (By Type and By Industry), Stage (Research, Preclinical, Clinical Phases and Commercial), End User (Biopharma, Contract Research Organizations (CROs), Contract Manufacturing Organization/Contract Development and Manufacturing Organization (CMOs/CDMOs), Academia, Hospitals, Clinical Labs and Others), Distribution Channel (Direct Tender, Retail Sales and Others), Country (Germany, France, Italy, U.K., Spain, Switzerland, Russia, Netherlands, Belgium, Turkey and Rest of Europe) Industry Trends and Forecast to 2028.

Some of the major factors contributing to the growth of the transfection market are:

  • Development of synthetic biology products.
  • Strategic initiatives by market players.

Market Players

The key market players for transfection market are listed below:

  • Mirus Bio LLC.
  • Promega Corporation
  • Polyplus Transfection
  • Bio-Rad Laboratories, Inc.
  • Merck KGaA, Lonza
  • MaxCyte, Inc.
  • PerkinElmer chemagen Technologie GmbH (A Subsidiary of PerkinElmer Inc.)
  • Cytiva
  • R&D Systems, Inc.
  • Takara Bio Inc.
  • QIAGEN
  • OriGene Technologies, Inc.
  • Applied Biological Materials Inc. (abm)
  • Beckman Coulter, Inc. (A Subsidiary of Danaher)
  • Amyris
  • Codexis
  • Autolus
  • SignaGen Laboratories
  • Bioscience

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 OBJECTIVES OF THE STUDY
  • 1.2 MARKET DEFINITION
  • 1.3 OVERVIEW OF EUROPE TRANSFECTION MARKET
  • 1.4 LIMITATIONS
  • 1.5 MARKETS COVERED

2 MARKET SEGMENTATION

  • 2.1 MARKETS COVERED
  • 2.2 GEOGRAPHICAL SCOPE
  • 2.3 YEARS CONSIDERED FOR THE STUDY
  • 2.4 CURRENCY AND PRICING
  • 2.5 DBMR TRIPOD DATA VALIDATION MODEL
  • 2.6 MULTIVARIATE MODELLING
  • 2.7 TRANSIENT TRANSFECTION OF TRANSFECTION LIFELINE CURVE
  • 2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
  • 2.9 DBMR MARKET POSITION GRID
  • 2.10 MARKET APPLICATION COVERAGE GRID
  • 2.11 VENDOR SHARE ANALYSIS
  • 2.12 SECONDARY SOURCES
  • 2.13 ASSUMPTIONS

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHT

  • 4.1 TOTAL ADDRESSABLE MARKET
    • 4.1.1 BY METHOD/MODALITY
    • 4.1.2 BY END USER
    • 4.1.3 BY APPLICATION
    • 4.1.4 BY STAGE
  • 4.2 EARLY AND LATE STAGE CELL LINE DEVELOPMENT FOR BIOPHARMA AND VIRAL VECTOR PRODUCTION FOR GENE THERAPY
    • 4.2.1 THE LIST OF APPROVED ANTIBODIES PRODUCED IN CHINESE HAMSTER OVARY (CHO) CELLS AND LIST OF SELECTABLE MARKERS USED IN MAMMALIAN EXPRESSION VECTORS

5 REGULATORY FRAMEWORK

  • 5.1 EUROPEAN UNION REGULATORY SCENARIO
  • 5.2 U.S. REGULATORY SCENARIO
  • 5.3 JAPAN REGULATORY SCENARIO
  • 5.4 CHINA REGULATORY SCENARIO

6 MARKET OVERVIEW

  • 6.1 DRIVERS
    • 6.1.1 RISE IN THE PREVALENCE OF CHRONIC DISEASES
    • 6.1.2 DEVELOPMENT OF SYNTHETIC BIOLOGY PRODUCTS
    • 6.1.3 GROWING DEMAND OF CHIMERIC GENES
    • 6.1.4 LARGE-SCALE TRANSFECTIONS USED IN CLINICAL RESEARCH
    • 6.1.5 UTILIZATION OF BIOPHARMACEUTICALS IN THE PRODUCTION OF PROTEINS
  • 6.2 RESTRAINTS
    • 6.2.1 HIGH COST OF TRANSFECTION PRODUCTS
    • 6.2.2 SELECTIVE EFFECTIVENESS OF TRANSFECTION REAGENTS
    • 6.2.3 CELL DAMAGE INDUCED BY TRANSFECTION PROCEDURE
  • 6.3 OPPORTUNITIES
    • 6.3.1 EXPLORATION OF EMERGING MARKET
    • 6.3.2 STRATEGIC INITIATIVES BY MARKET PLAYERS
    • 6.3.3 INCREASING GOVERNMENT SUPPORT
    • 6.3.4 SURGING LEVEL OF INVESTMENT
  • 6.4 CHALLENGES
    • 6.4.1 LONG APPROVAL PROCEDURE
    • 6.4.2 LACK OF SAFETY LEVEL LAB FOR VIRUS ASSOCIATED TRANSFECTION
    • 6.4.3 LACK OF TRAINED PROFESSIONALS

7 COVID-19 IMPACT OF EUROPE TRANSFECTION MARKET IN HEALTHCARE INDUSTRY

  • 7.1 OVERVIEW
  • 7.2 IMPACT ON THE PRICE
  • 7.3 IMPACT ON DEMAND
  • 7.4 IMPACT ON SUPPLY CHAIN
  • 7.5 STRATEGIC INITIATIVE BY MANUFACTURERS
  • 7.6 CONCLUSION

8 EUROPE TRANSFECTION MARKET, BY TYPE

  • 8.1 OVERVIEW
  • 8.2 TRANSIENT TRANSFECTION
    • 8.2.1 BY STAGE
      • 8.2.1.1 RESEARCH
      • 8.2.1.2 PRECLINICAL
      • 8.2.1.3 CLINICAL PHASES
      • 8.2.1.4 COMMERCIAL
    • 8.2.2 BY PRODUCT
      • 8.2.2.1 REAGENT & KITS
      • 8.2.2.2 INSTRUMENTS
      • 8.2.2.3 SOFTWARE
  • 8.3 STABLE TRANSECTION
    • 8.3.1 BY STAGE
      • 8.3.1.1 RESEARCH
      • 8.3.1.2 PRECLINICAL
      • 8.3.1.3 CLINICAL PHASES
      • 8.3.1.4 COMMERCIAL
    • 8.3.2 BY PRODUCT
      • 8.3.2.1 REAGENT & KITS
      • 8.3.2.2 INSTRUMENTS
      • 8.3.2.3 SOFTWARE

9 EUROPE TRANSFECTION MARKET, BY METHODS

  • 9.1 2.1 OVERVIEW
  • 9.2 NON- VIRAL METHODS
    • 9.2.1 CHEMICAL
      • 9.2.1.1 Lipofection Method
      • 9.2.1.2 Calcium Phosphate Precipitation Method
      • 9.2.1.3 Polyethylenimine (PEI)-DNA Condensation Method
      • 9.2.1.4 Others
    • 9.2.2 PHYSICAL
      • 9.2.2.1 Electroporation
      • 9.2.2.2 Direct Microinjection
      • 9.2.2.3 Biolistic Particle Delivery/ Particle Bombardment
      • 9.2.2.4 Magnetofection
      • 9.2.2.5 Sonoporation
      • 9.2.2.6 Others
  • 9.3 VIRAL METHODS
    • 9.3.1 RETROVIRUS TRANSFECTION
    • 9.3.2 ADENOVIRUS TRANSFECTION
    • 9.3.3 LENTIVIRUS TRANSFECTION
    • 9.3.4 OTHERS

10 EUROPE TRANSFECTION MARKET, BY METHODS

  • 10.1 OVERVIEW
  • 10.2 NON- VIRAL METHODS
    • 10.2.1 CHEMICAL
      • 10.2.1.1 Lipofection Method
      • 10.2.1.2 Calcium Phosphate Precipitation Method
      • 10.2.1.3 Polyethylenimine (PEI)-DNA Condensation Method
      • 10.2.1.4 Others
    • 10.2.2 PHYSICAL
      • 10.2.2.1 Electroporation
      • 10.2.2.2 Direct Microinjection
      • 10.2.2.3 Biolistic Particle Delivery/ Particle Bombardment
      • 10.2.2.4 Magnetofection
      • 10.2.2.5 Sonoporation
      • 10.2.2.6 Others
  • 10.3 VIRAL METHODS
    • 10.3.1 RETROVIRUS TRANSFECTION
    • 10.3.2 ADENOVIRUS TRANSFECTION
    • 10.3.3 LENTIVIRUS TRANSFECTION
    • 10.3.4 OTHERS

11 EUROPE TRANSFECTION MARKET, BY PRODUCTS

  • 11.1 OVERVIEW
  • 11.2 REAGENTS & KITS
    • 11.2.1 CATIONIC LIPIDS
      • 11.2.1.1 Liposomal Reagents
        • 11.2.1.1.1 L-Dioleoyl Phosphatidylethanolamine (DOPE)
        • 11.2.1.1.2 DOTAP [1,2-Dioleoyloxy-3-Trimethylammonium Propane]
        • 11.2.1.1.3 DOTMA [N-[1(2,3-Dioleoyloxy)Propyl]-N,N,N-Trimethylammonium Chloride]
        • 11.2.1.1.4 Others
      • 11.2.1.2 Non-Liposomal Reagents
        • 11.2.1.2.1 DNA Transfection Reagent
        • 11.2.1.2.2 siRNA Transfection Reagent
        • 11.2.1.2.3 Others
    • 11.2.2 CATIONIC POLYMER
      • 11.2.2.1 DEAE-Dextran
      • 11.2.2.2 Polybrene
      • 11.2.2.3 Polyethyleneimine
      • 11.2.2.4 Dendrimers
      • 11.2.2.5 Others
    • 11.2.3 NANOPARTICLES
      • 11.2.3.1 Systemic Intravenous Injection
      • 11.2.3.2 Direct Intratumoral Injection
    • 11.2.4 KITS
      • 11.2.4.1 Transporter Transfection Reagent
      • 11.2.4.2 GMP Transfection Reagent
      • 11.2.4.3 Neon Electroporation
      • 11.2.4.4 Cellfectin Ii Transfection Reagent
      • 11.2.4.5 DMRIE-C Transfection Reagent
      • 11.2.4.6 Lipofectamine Transfection Reagent
      • 11.2.4.7 Lipofectin Transfection Reagent
      • 11.2.4.8 Oligofectamine Transfection Reagent
      • 11.2.4.9 Optifect Transfection Reagent
      • 11.2.4.10 Cell Specific Transfection Reagent
      • 11.2.4.11 Gene Gun Kit
      • 11.2.4.12 Plasmid Transfection Reagent
      • 11.2.4.13 Others
    • 11.2.5 CUVETTE CHAMBER
    • 11.2.6 OTHERS
  • 11.3 INSTRUMENT
    • 11.3.1 ELECTROPORATION SYSTEM
      • 11.3.1.1 Neon Transfection System
      • 11.3.1.2 Others
    • 11.3.2 ELECTRO-CELL FUSION GENERATOR
    • 11.3.3 ELECTRO-KINETIC TRANSFECTION SYSTEM
    • 11.3.4 HEPTA SYSTEM
    • 11.3.5 TUBING PREP STATION
    • 11.3.6 RT-PCR
    • 11.3.7 GUN SYSTEM
    • 11.3.8 MICROPLATE READER
    • 11.3.9 SONOPORATION SYSTEM
    • 11.3.10 MICROSCOPES
    • 11.3.11 OTHERS

12 EUROPE TRANSFECTION MARKET, BY ORGANISM

  • 12.1 OVERVIEW
  • 12.2 MAMMALIAN CELLS
  • 12.3 PLANTS
  • 12.4 FUNGI
  • 12.5 VIRUS
  • 12.6 BACTERIA

13 EUROPE TRANSFECTION MARKET, BY TYPES OF MOLECULE

  • 13.1 OVERVIEW
  • 13.2 PLASMID DNA
  • 13.3 SMALL INTERFERING RNA (SIRNA)
  • 13.4 PROTEINS
  • 13.5 DNA OLIGONUCLEOTIDES
  • 13.6 RIBONUCLEOPROTEIN COMPLEXES (RNPS)
  • 13.7 OTHERS

14 EUROPE TRANSFECTION MARKET, BY APPLICATION

  • 14.1 OVERVIEW
  • 14.2 BY TYPE
    • 14.2.1 IN VITRO APPLICATION
      • 14.2.1.1 Gene Expression
      • 14.2.1.2 RNA Interference
    • 14.2.2 IN VIVO APPLICATION
      • 14.2.2.1 Gene Therapy
      • 14.2.2.2 Cellular-Based Therapy
    • 14.2.3 BIOPRODUCTION
      • 14.2.3.1 Antibody/Protein Production
      • 14.2.3.2 Virus Production
    • 14.2.4 OTHERS
  • 14.3 BY INDUSTRY
    • 14.3.1 SYNTHETIC BIOLOGY
      • 14.3.1.1 Biopharma
      • 14.3.1.2 Monoclonal Antibodies (mAbs)
      • 14.3.1.3 Recombinant Proteins
      • 14.3.1.4 Biofuels
      • 14.3.1.5 Cell Line Development
      • 14.3.1.6 Flavors & Fragrances
      • 14.3.1.7 Enzyme Engineering & Production
      • 14.3.1.8 Specialty Chemicals
    • 14.3.2 AGRICULTURE
    • 14.3.3 OTHERS

15 EUROPE TRANSFECTION MARKET, BY STAGES

  • 15.1 OVERVIEW
  • 15.2 RESEARCH
  • 15.3 PRECLINICAL
  • 15.4 CLINICAL PHASES
  • 15.5 COMMERCIAL

16 EUROPE TRANSFECTION MARKET, BY END USER

  • 16.1 OVERVIEW
  • 16.2 BIOPHARMA
  • 16.3 CONTRACT RESEARCH ORGANIZATIONS (CROS)
  • 16.4 CONTRACT MANUFACTURING ORGANIZATION/ CONTRACT DEVELOPMENT AND MANUFACTURING ORGANIZATION (CMOS/CDMOS)
  • 16.5 ACADEMIA
  • 16.6 HOSPITALS
  • 16.7 CLINICAL LABS
  • 16.8 OTHERS

17 EUROPE TRANSFECTION MARKET, BY DISTRIBUTION CHANNEL

  • 17.1 OVERVIEW
  • 17.2 DIRECT TENDERS
  • 17.3 RETAIL SALES
  • 17.4 OTHERS

18 EUROPE TRASNFECTION MARKET, BY GEOGRAPHY

  • 18.1 EUROPE
    • 18.1.1 GERMANY
    • 18.1.2 FRANCE
    • 18.1.3 ITALY
    • 18.1.4 U.K.
    • 18.1.5 SPAIN
    • 18.1.6 SWITZERLAND
    • 18.1.7 RUSSIA
    • 18.1.8 NETHERLANDS
    • 18.1.9 BELGIUM
    • 18.1.10 TURKEY
    • 18.1.11 REST OF EUROPE

19 EUROPE TRANSFECTION MARKET: COMPANY LANDSCAPE

  • 19.1 COMPANY SHARE ANALYSIS: EUROPE

20 SWOT ANALYSIS

21 COMPANY PROFILE

  • 21.1 THERMOFISHER SCIENTIFIC INC.
    • 21.1.1 COMPANY SNAPSHOT
    • 21.1.2 REVENUE ANALYSIS
    • 21.1.3 COMPANY SHARE ANALYSIS
    • 21.1.4 PRODUCT PORTFOLIO
    • 21.1.5 RECENT DEVELOPMENTS
  • 21.2 ROCHE MOLECULAR SYSTEMS, INC. (A SUBSIDIARY OF F. HOFFMANN-LA ROCHE LTD)
    • 21.2.1 COMPANY SNAPSHOT
    • 21.2.2 REVENUE ANALYSIS
    • 21.2.3 COMAPYN SHARE ANALYSIS
    • 21.2.4 PRODUCT PORTFOLIO
    • 21.2.5 RECENT DEVELOPMENTS
  • 21.3 QIAGEN
    • 21.3.1 COMPANY SNAPSHOT
    • 21.3.2 REVENUE ANALYSIS
    • 21.3.3 COMPANY SHARE ANALYSIS
    • 21.3.4 PRODUCT PORTFOLIO
    • 21.3.5 RECENT DEVELOPMENTS
  • 21.4 PROMEGA CORPORATION
    • 21.4.1 COMPANY SNAPSHOT
    • 21.4.2 COMPANY SHARE ANALYSIS
    • 21.4.3 PRODUCT PORTFOLIO
    • 21.4.4 RECENT DEVELOPMENTS
  • 21.5 TAKARA BIO INC.
    • 21.5.1 COMPANY SNAPSHOT
    • 21.5.2 REVENUE ANALYSIS
    • 21.5.3 COMPANY SHARE ANALYSIS
    • 21.5.4 PRODUCT PORTFOLIO
    • 21.5.5 RECENT DEVELOPMENTS
  • 21.6 BIO-RAD LABORATORIES, INC.
    • 21.6.1 COMPANY SNAPSHOT
    • 21.6.2 REVENUE ANANLYSIS
    • 21.6.3 PRODUCT PORTFOLIO
    • 21.6.4 RECENT DEVELOPMENT
  • 21.7 LONZA
    • 21.7.1 COMPANY SNAPSHOT
    • 21.7.2 REVENUE ANANLYSIS
    • 21.7.3 PRODUCT PORTFOLIO
    • 21.7.4 RECENT DEVELOPMENTS
  • 21.8 CYTIVA
    • 21.8.1 COMPANY SNAPSHOT
    • 21.8.2 PRODUCT PORTFOLIO
    • 21.8.3 RECENT DEVELOPMENTS
  • 21.9 ALTOGEN BIOSYSTEMS
    • 21.9.1 COMPANY SNAPSHOT
    • 21.9.2 PRODUCT PORTFOLIO
    • 21.9.3 RECENT DEVELOPMENTS
  • 21.10 AMYRIS
    • 21.10.1 COMPANY SNAPSHOT
    • 21.10.2 REVENUE ANALYSIS
    • 21.10.3 PRODUCT PORTFOLIO
    • 21.10.4 RECENT DEVELOPMENTS
  • 21.11 APPLIED BIOLOGICAL MATERIALS INC. (ABM)
    • 21.11.1 COMPANY SNAPSHOT
    • 21.11.2 PRODUCT PORTFOLIO
    • 21.11.3 RECENT DEVELOPMENT
  • 21.12 AUTOLUS
    • 21.12.1 COMPANY SNAPSHOT
    • 21.12.2 PRODUCT PORTFOLIO
    • 21.12.3 RECENT DEVELOPMENTS
  • 21.13 AVANTI POLAR LIPIDS (A SUBSIDIARY OF CRODA INTERNATIONAL PLC)
    • 21.13.1 COMPANY SNAPSHOT
    • 21.13.2 REVENUE ANALYSIS
    • 21.13.3 PRODUCT PORTFOLIO
    • 21.13.4 RECENT DEVELOPMENT
  • 21.14 BECKMAN COULTER, INC. (A SUBSIDIARY OF DANAHER)
    • 21.14.1 COMPANY SNAPSHOT
    • 21.14.2 REVENUE ANALYSIS
    • 21.14.3 PRODUCT PORTFOLIO
    • 21.14.4 RECENT DEVELOPMENTS
  • 21.15 CODEXIS
    • 21.15.1 COMPANY SNAPSHOT
    • 21.15.2 REVENUE ANALYSIS
    • 21.15.3 PRODUCT PORTFOLIO
    • 21.15.4 RECENT DEVELOPMENTS
  • 21.16 CONAGEN, INC.
    • 21.16.1 COMPANY SNAPSHOT
    • 21.16.2 PRODUCT PORTFOLIO
    • 21.16.3 RECENT DEVELOPMENTS
  • 21.17 FUJIFILM IRVINE SCIENTIFIC (A SUBSIDIARY OF FUJIFILM HOLDINGS CORPORATION)
    • 21.17.1 COMPANY SNAPSHOT
    • 21.17.2 REVENUE ANANLYSIS
    • 21.17.3 PRODUCT PORTFOLIO
    • 21.17.4 RECENT DEVELOPMENT
  • 21.18 GENLANTIS INC.
    • 21.18.1 COMPANY SNAPSHOT
    • 21.18.2 PRODUCT PORTFOLIO
    • 21.18.3 RECENT DEVELOPMENTS
  • 21.19 GENO TECHNOLOGY INC., USA
    • 21.19.1 COMPANY SNAPSHOT
    • 21.19.2 PRODUCT PORTFOLIO
    • 21.19.3 RECENT DEVELOPMENTS
  • 21.20 GINKGO BIOWORKS
    • 21.20.1 COMPANY SNAPSHOT
    • 21.20.2 PRODUCT PORTFOLIO
    • 21.20.3 RECENT DEVELOPMENTS
  • 21.21 IMPOSSIBLE FOODS INC
    • 21.21.1 COMPANY SNAPSHOT
    • 21.21.2 PRODUCT PORTFOLIO
    • 21.21.3 RECENT DEVELOPMENTS
  • 21.22 MAXCYTE, INC.
    • 21.22.1 COMPANY SNAPSHOT
    • 21.22.2 REVENUE ANALYSIS
    • 21.22.3 PRODUCT PORTFOLIO
    • 21.22.4 RECENT DEVELOPMENTS
  • 21.23 MERCK KGAA
    • 21.23.1 COMPANY SNAPSHOT
    • 21.23.2 REVENUE ANALYSIS
    • 21.23.3 PRODUCT PORTFOLIO
    • 21.23.4 RECENT DEVELOPMENTS
  • 21.24 MIRUS BIO LLC.
    • 21.24.1 COMPANY SNAPSHOT
    • 21.24.2 PRODUCT PORTFOLIO
    • 21.24.3 RECENT DEVELOPMENTS
  • 21.25 ORIGENE TECHNOLOGIES, INC.
    • 21.25.1 COMPANY SNAPSHOT
    • 21.25.2 PRODUCT PORTFOLIO
    • 21.25.3 RECENT DEVELOPMENTS
  • 21.26 PERKINELMER CHEMAGEN TECHNOLOGIE GMBH (A SUBSIDIARY OF PERKINELMER INC.)
    • 21.26.1 COMPANY SNAPSHOT
    • 21.26.2 REVENUE ANANLYSIS
    • 21.26.3 PRODUCT PORTFOLIO
    • 21.26.4 RECENT DEVELOPMENTS
  • 21.27 POLYPLUS TRANSFECTION
    • 21.27.1 COMPANY SNAPSHOT
    • 21.27.2 PRODUCT PORTFOLIO
    • 21.27.3 RECENT DEVELOPMENTS
  • 21.28 POSEIDA THERAPEUTICS, INC.
    • 21.28.1 COMPANY SNAPSHOT
    • 21.28.2 PRODUCT PORTFOLIO
    • 21.28.3 RECENT DEVELOPMENTS
  • 21.29 R&D SYSTEMS, INC.
    • 21.29.1 COMPANY SNAPSHOT
    • 21.29.2 PRODUCT PORTFOLIO
    • 21.29.3 RECENT DEVELOPMENT
  • 21.30 SBS GENETECH
    • 21.30.1 COMPANY SNAPSHOT
    • 21.30.2 PRODUCT PORTFOLIO
    • 21.30.3 RECENT DEVELOPMENTS
  • 21.31 SIGNAGEN LABORATORIES
    • 21.31.1 COMPANY SNAPSHOT
    • 21.31.2 PRODUCT PORTFOLIO
    • 21.31.3 RECENT DEVELOPMENTS
  • 21.32 TWIST BIOSCIENCE
    • 21.32.1 COMPANY SNAPSHOT
    • 21.32.2 REVENUE ANALYSIS
    • 21.32.3 PRODUCT PORTFOLIO
    • 21.32.4 RECENT DEVELOPMENTS
  • 21.33 VERVE THERAPEUTICS, INC.
    • 21.33.1 COMPANY SNAPSHOT
    • 21.33.2 PRODUCT PORTFOLIO
    • 21.33.3 RECENT DEVELOPMENTS
  • 21.34 ZYMERGEN INC.
    • 21.34.1 COMPANY SNAPSHOT
    • 21.34.2 PRODUCT PORTFOLIO
    • 21.34.3 RECENT DEVELOPMENTS

22 QUESTIONNAIRE

23 RELATED REPORTS

LIST OF TABLES

  • TABLE 1 LIST OF APPROVED ANTIBODIES PRODUCED IN CHO CELLS
  • TABLE 2 EU DIRECTIVES AND REGULATIONS RELATED TO CLINICAL TRIALS INVOLVING GTMPS
  • TABLE 3 GOVERNMENT ENTITIES THAT ARE IN CHARGE OF TYPE 2 USES
  • TABLE 4 EUROPE TRANSFECTION MARKET, BY TYPE, 2018-2028 (USD MILLION)
  • TABLE 5 EUROPE TRANSIENT TRANSFECTION IN TRANSFECTION MARKET, BY REGION, 2017-2027 (USD MILLION)
  • TABLE 6 EUROPE TRANSIENT TRANSFECTION (BY STAGE) IN TRANSFECTION MARKET, BY TYPE, 2019-2028 (USD MILLION)
  • TABLE 7 EUROPE TRANSIENT TRANSFECTION (BY PRODUCT) IN TRANSFECTION MARKET, BY TYPE, 2019-2028 (USD MILLION)
  • TABLE 8 EUROPE STABLE TRANSFECTION (BY STAGE) IN TRANSFECTION MARKET, BY TYPE, 2019-2028 (USD MILLION)
  • TABLE 9 EUROPE STABLE TRANSFECTION (BY PRODUCT) IN TRANSFECTION MARKET, BY TYPE, 2019-2028 (USD MILLION)
  • TABLE 10 EUROPE TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 11 EUROPE NON- VIRAL METHODS IN TRANSFECTION MARKET, BY REGION, 2017-2027 (USD MILLION)
  • TABLE 12 EUROPE NON-VIRAL METHODS IN TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 13 EUROPE CHEMICAL IN TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 14 EUROPE PHYSICAL IN TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 15 EUROPE VIRAL METHODS IN TRANSFECTION MARKET, BY REGION, 2017-2027 (USD MILLION)
  • TABLE 16 EUROPE VIRAL METHODS IN TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 17 EUROPE CRISPR TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 18 EUROPE NON- VIRAL METHODS IN TRANSFECTION MARKET, BY REGION, 2017-2027 (USD MILLION)
  • TABLE 19 EUROPE NON-VIRAL METHODS IN CRISPR TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 20 EUROPE CHEMICAL IN CRISPR TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 21 EUROPE PHYSICAL IN CRISPR TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 22 EUROPE VIRAL METHODS IN TRANSFECTION MARKET, BY REGION, 2017-2027 (USD MILLION)
  • TABLE 23 EUROPE VIRAL METHODS IN CRISPR TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 24 EUROPE REAGENTS & KITS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 25 EUROPE REAGENTS & KITS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 26 EUROPE CATIONIC LIPIDS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 27 EUROPE LIPOSOMAL REAGENTS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 28 EUROPE NON-LIPOSOMAL REAGENTS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 29 EUROPE CATIONIC POLYMER IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 30 EUROPE NANOPARTICLES IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 31 EUROPE KITS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 32 EUROPE INSTRUMENTS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 33 EUROPE INSTRUMENTS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 34 EUROPE ELECTROPORATION SYSTEM IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 35 EUROPE SOFTWARE BY INSTRUMENTS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 36 NORTH AMERICA TRANSFECTION MARKET, BY ORGANISM, 2019-2028 (USD MILLION)
  • TABLE 37 EUROPE MAMMALIAN CELLS IN TRANSFECTION MARKET, BY REGION, 2019-2028 (USD MILLION)
  • TABLE 38 EUROPE PLANTS IN TRANSFECTION MARKET, BY REGION, 2019-2028 (USD MILLION)
  • TABLE 39 EUROPE FUNGI IN TRANSFECTION MARKET, BY REGION, 2019-2028 (USD MILLION)
  • TABLE 40 EUROPE VIRUS IN TRANSFECTION MARKET, BY REGION, 2019-2028 (USD MILLION)
  • TABLE 41 EUROPE BACTERIA IN TRANSFECTION MARKET, BY REGION, 2019-2028 (USD MILLION)
  • TABLE 42 EUROPE TRANSFECTION MARKET, BY TYPES OF MOLECULE, 2019-2028 (USD MILLION)
  • TABLE 43 EUROPE PLASMID DNA IN TRANSFECTION MARKET, BY REGION, 2019-2028 (USD MILLION)
  • TABLE 44 EUROPE BACTERIA IN TRANSFECTION MARKET, BY REGION, 2019-2028 (USD MILLION)
  • TABLE 45 EUROPE PROTEINS IN TRANSFECTION MARKET, BY REGION, 2019-2028 (USD MILLION)
  • TABLE 46 EUROPE DNA OLIGONUCLEOTIDES IN TRANSFECTION MARKET, BY REGION, 2019-2028 (USD MILLION)
  • TABLE 47 EUROPE RIBONUCLEOPROTEIN COMPLEXES (RNPS) IN TRANSFECTION MARKET, BY REGION, 2019-2028 (USD MILLION)
  • TABLE 48 EUROPE BACTERIA IN TRANSFECTION MARKET, BY REGION, 2019-2028 (USD MILLION)
  • TABLE 49 EUROPETRANSFECTION MARKET (BY TYPE), BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 50 EUROPE IN VITRO APPLICATION IN TRANSFECTION MARKET, BY REGION, 2019-2028 (USD MILLION)
  • TABLE 51 NORTH AMERICA IN VITRO APPLICATION IN TRANSFECTION MARKET (BY TYPE), BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 52 EUROPE IN VIVO APPLICATION IN TRANSFECTION MARKET, BY REGION, 2019-2028 (USD MILLION)
  • TABLE 53 NORTH AMERICA IN VIVO APPLICATION IN TRANSFECTION MARKET (BY TYPE), BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 54 EUROPE BIOPRODUCTION IN TRANSFECTION MARKET, BY REGION, 2019-2028 (USD MILLION)
  • TABLE 55 NORTH AMERICA BIOPRODUCTION IN TRANSFECTION MARKET (BY TYPE), BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 56 EUROPE OTHERS IN TRANSFECTION MARKET, BY REGION, 2019-2028 (USD MILLION)
  • TABLE 57 EUROPE TRANSFECTION MARKET (BY INDUSTRY), BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 58 EUROPE SYNTHETIC BIOLOGY IN TRANSFECTION MARKET, BY REGION, 2019-2028 (USD MILLION)
  • TABLE 59 NORTH AMERICA SYNTHETIC BIOLOGY IN TRANSFECTION MARKET (BY INDUSTRY), BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 60 EUROPE AGRICULTURE IN TRANSFECTION MARKET, BY REGION, 2019-2028 (USD MILLION)
  • TABLE 61 EUROPE OTHERS IN TRANSFECTION MARKET, BY REGION, 2019-2028 (USD MILLION)
  • TABLE 62 NORTH AMERICA TRANSFECTION MARKET, BY STAGE, 2019-2028 (USD MILLION)
  • TABLE 63 EUROPE RESEARCH IN TRANSFECTION MARKET, BY REGION, 2017-2027 (USD MILLION)
  • TABLE 64 EUROPE PRE-CLINICAL IN TRANSFECTION MARKET, BY REGION, 2017-2027 (USD MILLION)
  • TABLE 65 EUROPE CLINICAL PHASES IN TRANSFECTION MARKET, BY REGION, 2019-2028 (USD MILLION)
  • TABLE 66 EUROPE COMMERCIAL IN TRANSFECTION MARKET, BY REGION, 2019-2028 (USD MILLION)
  • TABLE 67 NORTH AMERICA TRANSFECTION MARKET, BY END USER, 2019-2028 (USD MILLION)
  • TABLE 68 EUROPE BIOPHARMA IN TRANSFECTION MARKET, BY REGION, 2019-2028 (USD MILLION)
  • TABLE 69 EUROPE CONTRACT RESEARCH ORGANIZATIONS (CROS) IN TRANSFECTION MARKET, BY REGION, 2019-2028 (USD MILLION)
  • TABLE 70 EUROPE CONTRACT MANUFACTURING ORGANIZATION/ CONTRACT DEVELOPMENT AND MANUFACTURING ORGANIZATION (CMOS/CDMOS) IN TRANSFECTION MARKET, BY REGION, 2019-2028 (USD MILLION)
  • TABLE 71 EUROPE ACADEMIA IN TRANSFECTION MARKET, BY REGION, 2019-2028 (USD MILLION)
  • TABLE 72 EUROPE HOSPITALS IN TRANSFECTION MARKET, BY REGION, 2019-2028 (USD MILLION)
  • TABLE 73 EUROPE CLINICAL LABS IN TRANSFECTION MARKET, BY REGION, 2019-2028 (USD MILLION)
  • TABLE 74 EUROPE OTHERS IN TRANSFECTION MARKET, BY REGION, 2019-2028 (USD MILLION)
  • TABLE 75 NORTH AMERICA TRANSFECTION MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
  • TABLE 76 EUROPE DIRECT TENDER IN TRANSFECTION MARKET, BY REGION, 2019-2028 (USD MILLION)
  • TABLE 77 EUROPE RETAIL SALES IN TRANSFECTION MARKET, BY REGION, 2019-2028 (USD MILLION)
  • TABLE 78 EUROPE OTHERS IN TRANSFECTION MARKET, BY REGION, 2019-2028 (USD MILLION)
  • TABLE 1 EUROPE TRANSFECTION MARKET, BY COUNTRY, 2018-2028 (USD MILLION)
  • TABLE 2 EUROPE TRANSFECTION MARKET, BY TYPE, 2018-2028 (USD MILLION)
  • TABLE 3 EUROPE TRANSIENT TRANSFECTION (BY STAGE) IN TRANSFECTION MARKET, BY TYPE, 2019-2028 (USD MILLION)
  • TABLE 4 EUROPE TRANSIENT TRANSFECTION (BY PRODUCT) IN TRANSFECTION MARKET, BY TYPE, 2019-2028 (USD MILLION)
  • TABLE 5 EUROPE STABLE TRANSFECTION (BY STAGE) IN TRANSFECTION MARKET, BY TYPE, 2019-2028 (USD MILLION)
  • TABLE 6 EUROPE STABLE TRANSFECTION (BY PRODUCT) IN TRANSFECTION MARKET, BY TYPE, 2019-2028 (USD MILLION)
  • TABLE 7 EUROPE TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 8 EUROPE NON-VIRAL METHODS IN TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 9 EUROPE CHEMICAL IN TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 10 EUROPE PHYSICAL IN TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 11 EUROPE VIRAL METHODS IN TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 12 EUROPE CRISPR TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 13 EUROPE NON-VIRAL METHODS IN CRISPR TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 14 EUROPE CHEMICAL IN CRISPR TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 15 EUROPE PHYSICAL IN CRISPR TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 16 EUROPE VIRAL METHODS IN CRISPR TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 17 EUROPE TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 18 EUROPE REAGENTS & KITS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 19 EUROPE CATIONIC LIPIDS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 20 EUROPE LIPOSOMAL REAGENTS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 21 EUROPE NON-LIPOSOMAL REAGENTS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 22 EUROPE CATIONIC POLYMER IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 23 EUROPE KITS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 24 EUROPE NANOPARTICLES IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 25 EUROPE INSTRUMENTS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 26 EUROPE INSTRUMENTS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (UNITS)
  • TABLE 27 EUROPE ELECTROPORATION SYSTEM IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 28 EUROPE TRANSFECTION MARKET, BY ORGANISM, 2019-2028 (USD MILLION)
  • TABLE 29 EUROPE TRANSFECTION MARKET, BY TYPES OF MOLECULE, 2019-2028 (USD MILLION)
  • TABLE 30 EUROPE AMERICATRANSFECTION MARKET (BY TYPE), BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 31 EUROPE IN VITRO APPLICATION IN TRANSFECTION MARKET (BY TYPE), BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 32 EUROPE IN VIVO APPLICATION IN TRANSFECTION MARKET (BY TYPE), BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 33 EUROPE BIOPRODUCTION IN TRANSFECTION MARKET (BY TYPE), BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 34 EUROPE TRANSFECTION MARKET (BY INDUSTRY), BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 35 EUROPE SYNTHETIC BIOLOGY IN TRANSFECTION MARKET (BY INDUSTRY), BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 36 EUROPE TRANSFECTION MARKET, BY STAGE, 2019-2028 (USD MILLION)
  • TABLE 37 EUROPE TRANSFECTION MARKET, BY END USER, 2019-2028 (USD MILLION)
  • TABLE 38 EUROPE TRANSFECTION MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
  • TABLE 39 GERMANY TRANSFECTION MARKET, BY TYPE, 2018-2028 (USD MILLION)
  • TABLE 40 GERMANY TRANSIENT TRANSFECTION (BY STAGE) IN TRANSFECTION MARKET, BY TYPE, 2019-2028 (USD MILLION)
  • TABLE 41 GERMANY TRANSIENT TRANSFECTION (BY PRODUCT) IN TRANSFECTION MARKET, BY TYPE, 2019-2028 (USD MILLION)
  • TABLE 42 GERMANY STABLE TRANSFECTION (BY STAGE) IN TRANSFECTION MARKET, BY TYPE, 2019-2028 (USD MILLION)
  • TABLE 43 GERMANY STABLE TRANSFECTION (BY PRODUCT) IN TRANSFECTION MARKET, BY TYPE, 2019-2028 (USD MILLION)
  • TABLE 44 GERMANY TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 45 GERMANY NON-VIRAL METHODS IN TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 46 GERMANY CHEMICAL IN TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 47 GERMANY PHYSICAL IN TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 48 GERMANY VIRAL METHODS IN TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 49 GERMANY CRISPR TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 50 GERMANY NON-VIRAL METHODS IN CRISPR TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 51 GERMANY CHEMICAL IN CRISPR TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 52 GERMANY PHYSICAL IN CRISPR TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 53 GERMANY VIRAL METHODS IN CRISPR TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 54 GERMANY TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 55 GERMANY REAGENTS & KITS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 56 GERMANY CATIONIC LIPIDS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 57 GERMANY LIPOSOMAL REAGENTS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 58 GERMANY NON-LIPOSOMAL REAGENTS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 59 GERMANY CATIONIC POLYMER IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 60 GERMANY KITS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 61 GERMANY NANOPARTICLES IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 62 GERMANY INSTRUMENTS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 63 GERMANY INSTRUMENTS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (UNITS)
  • TABLE 64 GERMANY ELECTROPORATION SYSTEM IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 65 GERMANY TRANSFECTION MARKET, BY ORGANISM, 2019-2028 (USD MILLION)
  • TABLE 66 GERMANY TRANSFECTION MARKET, BY TYPES OF MOLECULE, 2019-2028 (USD MILLION)
  • TABLE 67 GERMANY TRANSFECTION MARKET (BY TYPE), BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 68 GERMANY IN VITRO APPLICATION IN TRANSFECTION MARKET (BY TYPE), BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 69 GERMANY IN VIVO APPLICATION IN TRANSFECTION MARKET (BY TYPE), BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 70 GERMANY BIOPRODUCTION IN TRANSFECTION MARKET (BY TYPE), BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 71 GERMANY TRANSFECTION MARKET (BY INDUSTRY), BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 72 GERMANY SYNTHETIC BIOLOGY IN TRANSFECTION MARKET (BY INDUSTRY), BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 73 GERMANY TRANSFECTION MARKET, BY STAGE, 2019-2028 (USD MILLION)
  • TABLE 74 GERMANY TRANSFECTION MARKET, BY END USER, 2019-2028 (USD MILLION)
  • TABLE 75 GERMANY TRANSFECTION MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
  • TABLE 76 FRANCE TRANSFECTION MARKET, BY TYPE, 2018-2028 (USD MILLION)
  • TABLE 77 FRANCE TRANSIENT TRANSFECTION (BY STAGE) IN TRANSFECTION MARKET, BY TYPE, 2019-2028 (USD MILLION)
  • TABLE 78 FRANCE TRANSIENT TRANSFECTION (BY PRODUCT) IN TRANSFECTION MARKET, BY TYPE, 2019-2028 (USD MILLION)
  • TABLE 79 FRANCE STABLE TRANSFECTION (BY STAGE) IN TRANSFECTION MARKET, BY TYPE, 2019-2028 (USD MILLION)
  • TABLE 80 FRANCE STABLE TRANSFECTION (BY PRODUCT) IN TRANSFECTION MARKET, BY TYPE, 2019-2028 (USD MILLION)
  • TABLE 81 FRANCE TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 82 FRANCE NON-VIRAL METHODS IN TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 83 FRANCE CHEMICAL IN TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 84 FRANCE PHYSICAL IN TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 85 FRANCE VIRAL METHODS IN TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 86 FRANCE CRISPR TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 87 FRANCE NON-VIRAL METHODS IN CRISPR TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 88 FRANCE CHEMICAL IN CRISPR TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 89 FRANCE PHYSICAL IN CRISPR TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 90 FRANCE VIRAL METHODS IN CRISPR TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 91 FRANCE TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 92 FRANCE REAGENTS & KITS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 93 FRANCE CATIONIC LIPIDS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 94 FRANCE LIPOSOMAL REAGENTS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 95 FRANCE NON-LIPOSOMAL REAGENTS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 96 FRANCE CATIONIC POLYMER IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 97 FRANCE KITS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 98 FRANCE NANOPARTICLES IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 99 FRANCE INSTRUMENTS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 100 FRANCE INSTRUMENTS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (UNITS)
  • TABLE 101 FRANCE ELECTROPORATION SYSTEM IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 102 FRANCE TRANSFECTION MARKET, BY ORGANISM, 2019-2028 (USD MILLION)
  • TABLE 103 FRANCE TRANSFECTION MARKET, BY TYPES OF MOLECULE, 2019-2028 (USD MILLION)
  • TABLE 104 FRANCE TRANSFECTION MARKET (BY TYPE), BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 105 FRANCE IN VITRO APPLICATION IN TRANSFECTION MARKET (BY TYPE), BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 106 FRANCE IN VIVO APPLICATION IN TRANSFECTION MARKET (BY TYPE), BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 107 FRANCE BIOPRODUCTION IN TRANSFECTION MARKET (BY TYPE), BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 108 FRANCE TRANSFECTION MARKET (BY INDUSTRY), BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 109 CANADA SYNTHETIC BIOLOGY IN TRANSFECTION MARKET (BY INDUSTRY), BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 110 FRANCE TRANSFECTION MARKET, BY STAGE, 2019-2028 (USD MILLION)
  • TABLE 111 FRANCE TRANSFECTION MARKET, BY END USER, 2019-2028 (USD MILLION)
  • TABLE 112 FRANCE TRANSFECTION MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
  • TABLE 113 ITALY TRANSFECTION MARKET, BY TYPE, 2018-2028 (USD MILLION)
  • TABLE 114 ITALY TRANSIENT TRANSFECTION (BY STAGE) IN TRANSFECTION MARKET, BY TYPE, 2019-2028 (USD MILLION)
  • TABLE 115 ITALY TRANSIENT TRANSFECTION (BY PRODUCT) IN TRANSFECTION MARKET, BY TYPE, 2019-2028 (USD MILLION)
  • TABLE 116 ITALY STABLE TRANSFECTION (BY STAGE) IN TRANSFECTION MARKET, BY TYPE, 2019-2028 (USD MILLION)
  • TABLE 117 ITALY STABLE TRANSFECTION (BY PRODUCT) IN TRANSFECTION MARKET, BY TYPE, 2019-2028 (USD MILLION)
  • TABLE 118 ITALY TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 119 ITALY NON-VIRAL METHODS IN TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 120 ITALY CHEMICAL IN TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 121 ITALY PHYSICAL IN TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 122 ITALY VIRAL METHODS IN TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 123 ITALY CRISPR TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 124 ITALY NON-VIRAL METHODS IN CRISPR TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 125 ITALY CHEMICAL IN CRISPR TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 126 ITALY PHYSICAL IN CRISPR TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 127 ITALY VIRAL METHODS IN CRISPR TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 128 ITALY TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 129 ITALY REAGENTS & KITS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 130 ITALY CATIONIC LIPIDS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 131 ITALY LIPOSOMAL REAGENTS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 132 ITALY NON-LIPOSOMAL REAGENTS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 133 ITALY CATIONIC POLYMER IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 134 ITALY KITS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 135 ITALY NANOPARTICLES IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 136 ITALY INSTRUMENTS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 137 ITALY INSTRUMENTS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (UNITS)
  • TABLE 138 ITALY ELECTROPORATION SYSTEM IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 139 ITALY TRANSFECTION MARKET, BY ORGANISM, 2019-2028 (USD MILLION)
  • TABLE 140 ITALY TRANSFECTION MARKET, BY TYPES OF MOLECULE, 2019-2028 (USD MILLION)
  • TABLE 141 ITALY TRANSFECTION MARKET (BY TYPE), BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 142 ITALY IN VITRO APPLICATION IN TRANSFECTION MARKET (BY TYPE), BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 143 ITALY IN VIVO APPLICATION IN TRANSFECTION MARKET (BY TYPE), BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 144 ITALY BIOPRODUCTION IN TRANSFECTION MARKET (BY TYPE), BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 145 ITALY TRANSFECTION MARKET (BY INDUSTRY), BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 146 ITALY SYNTHETIC BIOLOGY IN TRANSFECTION MARKET (BY INDUSTRY), BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 147 ITALY TRANSFECTION MARKET, BY STAGE, 2019-2028 (USD MILLION)
  • TABLE 148 ITALY TRANSFECTION MARKET, BY END USER, 2019-2028 (USD MILLION)
  • TABLE 149 ITALY TRANSFECTION MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
  • TABLE 150 UK TRANSFECTION MARKET, BY TYPE, 2018-2028 (USD MILLION)
  • TABLE 151 UK TRANSIENT TRANSFECTION (BY STAGE) IN TRANSFECTION MARKET, BY TYPE, 2019-2028 (USD MILLION)
  • TABLE 152 UK TRANSIENT TRANSFECTION (BY PRODUCT) IN TRANSFECTION MARKET, BY TYPE, 2019-2028 (USD MILLION)
  • TABLE 153 UK STABLE TRANSFECTION (BY STAGE) IN TRANSFECTION MARKET, BY TYPE, 2019-2028 (USD MILLION)
  • TABLE 154 UK STABLE TRANSFECTION (BY PRODUCT) IN TRANSFECTION MARKET, BY TYPE, 2019-2028 (USD MILLION)
  • TABLE 155 UK TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 156 UK NON-VIRAL METHODS IN TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 157 UK CHEMICAL IN TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 158 UK PHYSICAL IN TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 159 UK VIRAL METHODS IN TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 160 UK CRISPR TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 161 UK NON-VIRAL METHODS IN CRISPR TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 162 UK CHEMICAL IN CRISPR TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 163 UK PHYSICAL IN CRISPR TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 164 UK VIRAL METHODS IN CRISPR TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 165 UK TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 166 UK REAGENTS & KITS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 167 UK CATIONIC LIPIDS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 168 UK LIPOSOMAL REAGENTS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 169 UK NON-LIPOSOMAL REAGENTS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 170 UK CATIONIC POLYMER IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 171 UK KITS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 172 UK NANOPARTICLES IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 173 UK INSTRUMENTS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 174 UK INSTRUMENTS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (UNITS)
  • TABLE 175 UK ELECTROPORATION SYSTEM IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 176 UK TRANSFECTION MARKET, BY ORGANISM, 2019-2028 (USD MILLION)
  • TABLE 177 UK TRANSFECTION MARKET, BY TYPES OF MOLECULE, 2019-2028 (USD MILLION)
  • TABLE 178 UKTRANSFECTION MARKET (BY TYPE), BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 179 UK IN VITRO APPLICATION IN TRANSFECTION MARKET (BY TYPE), BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 180 UK IN VIVO APPLICATION IN TRANSFECTION MARKET (BY TYPE), BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 181 UK BIOPRODUCTION IN TRANSFECTION MARKET (BY TYPE), BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 182 UK TRANSFECTION MARKET (BY INDUSTRY), BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 183 UK SYNTHETIC BIOLOGY IN TRANSFECTION MARKET (BY INDUSTRY), BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 184 UK TRANSFECTION MARKET, BY STAGE, 2019-2028 (USD MILLION)
  • TABLE 185 UK TRANSFECTION MARKET, BY END USER, 2019-2028 (USD MILLION)
  • TABLE 186 UK TRANSFECTION MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
  • TABLE 187 SPAIN TRANSFECTION MARKET, BY TYPE, 2018-2028 (USD MILLION)
  • TABLE 188 SPAIN TRANSIENT TRANSFECTION (BY STAGE) IN TRANSFECTION MARKET, BY TYPE, 2019-2028 (USD MILLION)
  • TABLE 189 SPAIN TRANSIENT TRANSFECTION (BY PRODUCT) IN TRANSFECTION MARKET, BY TYPE, 2019-2028 (USD MILLION)
  • TABLE 190 SPAIN STABLE TRANSFECTION (BY STAGE) IN TRANSFECTION MARKET, BY TYPE, 2019-2028 (USD MILLION)
  • TABLE 191 SPAIN STABLE TRANSFECTION (BY PRODUCT) IN TRANSFECTION MARKET, BY TYPE, 2019-2028 (USD MILLION)
  • TABLE 192 SPAIN TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 193 SPAIN NON-VIRAL METHODS IN TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 194 SPAIN CHEMICAL IN TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 195 SPAIN PHYSICAL IN TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 196 SPAIN VIRAL METHODS IN TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 197 SPAIN CRISPR TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 198 SPAIN NON-VIRAL METHODS IN CRISPR TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 199 SPAIN CHEMICAL IN CRISPR TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 200 SPAIN PHYSICAL IN CRISPR TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 201 SPAIN VIRAL METHODS IN CRISPR TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 202 SPAIN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 203 SPAIN REAGENTS & KITS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 204 SPAIN CATIONIC LIPIDS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 205 SPAIN LIPOSOMAL REAGENTS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 206 SPAIN NON-LIPOSOMAL REAGENTS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 207 SPAIN CATIONIC POLYMER IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 208 SPAIN KITS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 209 SPAIN NANOPARTICLES IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 210 SPAIN INSTRUMENTS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 211 SPAIN INSTRUMENTS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (UNITS)
  • TABLE 212 SPAIN ELECTROPORATION SYSTEM IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 213 SPAIN TRANSFECTION MARKET, BY ORGANISM, 2019-2028 (USD MILLION)
  • TABLE 214 SPAIN TRANSFECTION MARKET, BY TYPES OF MOLECULE, 2019-2028 (USD MILLION)
  • TABLE 215 SPAIN TRANSFECTION MARKET (BY TYPE), BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 216 SPAIN IN VITRO APPLICATION IN TRANSFECTION MARKET (BY TYPE), BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 217 SPAIN IN VIVO APPLICATION IN TRANSFECTION MARKET (BY TYPE), BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 218 SPAIN BIOPRODUCTION IN TRANSFECTION MARKET (BY TYPE), BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 219 SPAIN TRANSFECTION MARKET (BY INDUSTRY), BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 220 SPAIN SYNTHETIC BIOLOGY IN TRANSFECTION MARKET (BY INDUSTRY), BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 221 SPAIN TRANSFECTION MARKET, BY STAGE, 2019-2028 (USD MILLION)
  • TABLE 222 SPAIN TRANSFECTION MARKET, BY END USER, 2019-2028 (USD MILLION)
  • TABLE 223 SPAIN TRANSFECTION MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
  • TABLE 224 SWITZERLAND TRANSFECTION MARKET, BY TYPE, 2018-2028 (USD MILLION)
  • TABLE 225 SWITZERLAND TRANSIENT TRANSFECTION (BY STAGE) IN TRANSFECTION MARKET, BY TYPE, 2019-2028 (USD MILLION)
  • TABLE 226 SWITZERLAND TRANSIENT TRANSFECTION (BY PRODUCT) IN TRANSFECTION MARKET, BY TYPE, 2019-2028 (USD MILLION)
  • TABLE 227 SWITZERLAND STABLE TRANSFECTION (BY STAGE) IN TRANSFECTION MARKET, BY TYPE, 2019-2028 (USD MILLION)
  • TABLE 228 SWITZERLAND STABLE TRANSFECTION (BY PRODUCT) IN TRANSFECTION MARKET, BY TYPE, 2019-2028 (USD MILLION)
  • TABLE 229 SWITZERLAND TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 230 SWITZERLAND NON-VIRAL METHODS IN TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 231 SWITZERLAND CHEMICAL IN TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 232 SWITZERLAND PHYSICAL IN TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 233 SWITZERLAND VIRAL METHODS IN TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 234 SWITZERLAND CRISPR TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 235 SWITZERLAND NON-VIRAL METHODS IN CRISPR TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 236 SWITZERLAND CHEMICAL IN CRISPR TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 237 SWITZERLAND PHYSICAL IN CRISPR TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 238 SWITZERLAND VIRAL METHODS IN CRISPR TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 239 SWITZERLAND TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 240 SWITZERLAND REAGENTS & KITS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 241 SWITZERLAND CATIONIC LIPIDS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 242 SWITZERLAND LIPOSOMAL REAGENTS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 243 SWITZERLAND NON-LIPOSOMAL REAGENTS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 244 SWITZERLAND CATIONIC POLYMER IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 245 SWITZERLAND KITS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 246 SWITZERLAND NANOPARTICLES IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 247 SWITZERLAND INSTRUMENTS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 248 SWITZERLAND INSTRUMENTS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (UNITS)
  • TABLE 249 SWITZERLAND ELECTROPORATION SYSTEM IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 250 SWITZERLAND TRANSFECTION MARKET, BY ORGANISM, 2019-2028 (USD MILLION)
  • TABLE 251 SWITZERLAND TRANSFECTION MARKET, BY TYPES OF MOLECULE, 2019-2028 (USD MILLION)
  • TABLE 252 SWITZERLAND TRANSFECTION MARKET (BY TYPE), BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 253 SWITZERLAND IN VITRO APPLICATION IN TRANSFECTION MARKET (BY TYPE), BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 254 SWITZERLAND IN VIVO APPLICATION IN TRANSFECTION MARKET (BY TYPE), BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 255 SWITZERLAND BIOPRODUCTION IN TRANSFECTION MARKET (BY TYPE), BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 256 SWITZERLAND TRANSFECTION MARKET (BY INDUSTRY), BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 257 SWITZERLAND SYNTHETIC BIOLOGY IN TRANSFECTION MARKET (BY INDUSTRY), BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 258 SWITZERLAND TRANSFECTION MARKET, BY STAGE, 2019-2028 (USD MILLION)
  • TABLE 259 SWITZERLAND TRANSFECTION MARKET, BY END USER, 2019-2028 (USD MILLION)
  • TABLE 260 SWITZERLAND TRANSFECTION MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
  • TABLE 261 RUSSIA TRANSFECTION MARKET, BY TYPE, 2018-2028 (USD MILLION)
  • TABLE 262 RUSSIA TRANSIENT TRANSFECTION (BY STAGE) IN TRANSFECTION MARKET, BY TYPE, 2019-2028 (USD MILLION)
  • TABLE 263 RUSSIA TRANSIENT TRANSFECTION (BY PRODUCT) IN TRANSFECTION MARKET, BY TYPE, 2019-2028 (USD MILLION)
  • TABLE 264 RUSSIA STABLE TRANSFECTION (BY STAGE) IN TRANSFECTION MARKET, BY TYPE, 2019-2028 (USD MILLION)
  • TABLE 265 RUSSIA STABLE TRANSFECTION (BY PRODUCT) IN TRANSFECTION MARKET, BY TYPE, 2019-2028 (USD MILLION)
  • TABLE 266 RUSSIA TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 267 RUSSIA NON-VIRAL METHODS IN TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 268 RUSSIA CHEMICAL IN TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 269 RUSSIA PHYSICAL IN TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 270 RUSSIA VIRAL METHODS IN TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 271 RUSSIA CRISPR TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 272 RUSSIA NON-VIRAL METHODS IN CRISPR TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 273 RUSSIA CHEMICAL IN CRISPR TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 274 RUSSIA PHYSICAL IN CRISPR TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 275 RUSSIA VIRAL METHODS IN CRISPR TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 276 RUSSIA TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 277 RUSSIA REAGENTS & KITS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 278 RUSSIA CATIONIC LIPIDS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 279 RUSSIA LIPOSOMAL REAGENTS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 280 RUSSIA NON-LIPOSOMAL REAGENTS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 281 RUSSIA CATIONIC POLYMER IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 282 RUSSIA KITS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 283 RUSSIA NANOPARTICLES IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 284 RUSSIA INSTRUMENTS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 285 RUSSIA INSTRUMENTS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (UNITS)
  • TABLE 286 RUSSIA ELECTROPORATION SYSTEM IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 287 RUSSIA TRANSFECTION MARKET, BY ORGANISM, 2019-2028 (USD MILLION)
  • TABLE 288 RUSSIA TRANSFECTION MARKET, BY TYPES OF MOLECULE, 2019-2028 (USD MILLION)
  • TABLE 289 RUSSIATRANSFECTION MARKET (BY TYPE), BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 290 RUSSIA IN VITRO APPLICATION IN TRANSFECTION MARKET (BY TYPE), BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 291 RUSSIA IN VIVO APPLICATION IN TRANSFECTION MARKET (BY TYPE), BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 292 RUSSIA BIOPRODUCTION IN TRANSFECTION MARKET (BY TYPE), BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 293 RUSSIA TRANSFECTION MARKET (BY INDUSTRY), BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 294 RUSSIA SYNTHETIC BIOLOGY IN TRANSFECTION MARKET (BY INDUSTRY), BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 295 RUSSIA TRANSFECTION MARKET, BY STAGE, 2019-2028 (USD MILLION)
  • TABLE 296 RUSSIA TRANSFECTION MARKET, BY END USER, 2019-2028 (USD MILLION)
  • TABLE 297 RUSSIA TRANSFECTION MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
  • TABLE 298 NETHERLANDS TRANSFECTION MARKET, BY TYPE, 2019-2028 (USD MILLION)
  • TABLE 299 NETHERLANDS TRANSIENT TRANSFECTION (BY STAGE) IN TRANSFECTION MARKET, BY TYPE, 2019-2028 (USD MILLION)
  • TABLE 300 NETHERLANDS TRANSIENT TRANSFECTION (BY PRODUCT) IN TRANSFECTION MARKET, BY TYPE, 2019-2028 (USD MILLION)
  • TABLE 301 NETHERLANDS STABLE TRANSFECTION (BY STAGE) IN TRANSFECTION MARKET, BY TYPE, 2019-2028 (USD MILLION)
  • TABLE 302 NETHERLANDS STABLE TRANSFECTION (BY PRODUCT) IN TRANSFECTION MARKET, BY TYPE, 2019-2028 (USD MILLION)
  • TABLE 303 NETHERLANDS TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 304 NETHERLANDS NON-VIRAL METHODS IN TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 305 NETHERLANDS CHEMICAL IN TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 306 NETHERLANDS PHYSICAL IN TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 307 NETHERLANDS VIRAL METHODS IN TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 308 NETHERLANDS CRISPR TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 309 NETHERLANDS NON-VIRAL METHODS IN CRISPR TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 310 NETHERLANDS CHEMICAL IN CRISPR TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 311 NETHERLANDS PHYSICAL IN CRISPR TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 312 NETHERLANDS VIRAL METHODS IN CRISPR TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 313 NETHERLANDS TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 314 NETHERLANDS REAGENTS & KITS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 315 NETHERLANDS CATIONIC LIPIDS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 316 NETHERLANDS LIPOSOMAL REAGENTS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 317 NETHERLANDS NON-LIPOSOMAL REAGENTS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 318 NETHERLANDS CATIONIC POLYMER IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 319 NETHERLANDS KITS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 320 NETHERLANDS NANOPARTICLES IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 321 NETHERLANDS INSTRUMENTS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 322 NETHERLANDS INSTRUMENTS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (UNITS)
  • TABLE 323 NETHERLANDS ELECTROPORATION SYSTEM IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 324 NETHERLANDS TRANSFECTION MARKET, BY ORGANISM, 2019-2028 (USD MILLION)
  • TABLE 325 NETHERLANDS TRANSFECTION MARKET, BY TYPES OF MOLECULE, 2019-2028 (USD MILLION)
  • TABLE 326 NETHERLANDSTRANSFECTION MARKET (BY TYPE), BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 327 NETHERLANDS IN VITRO APPLICATION IN TRANSFECTION MARKET (BY TYPE), BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 328 NETHERLANDS IN VIVO APPLICATION IN TRANSFECTION MARKET (BY TYPE), BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 329 NETHERLANDS BIOPRODUCTION IN TRANSFECTION MARKET (BY TYPE), BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 330 NETHERLANDS TRANSFECTION MARKET (BY INDUSTRY), BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 331 NETHERLANDS SYNTHETIC BIOLOGY IN TRANSFECTION MARKET (BY INDUSTRY), BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 332 NETHERLANDS TRANSFECTION MARKET, BY STAGE, 2019-2028 (USD MILLION)
  • TABLE 333 NETHERLANDS TRANSFECTION MARKET, BY END USER, 2019-2028 (USD MILLION)
  • TABLE 334 NETHERLANDS TRANSFECTION MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
  • TABLE 335 BELGIUM TRANSFECTION MARKET, BY TYPE, 2019-2028 (USD MILLION)
  • TABLE 336 BELGIUM TRANSIENT TRANSFECTION (BY STAGE) IN TRANSFECTION MARKET, BY TYPE, 2019-2028 (USD MILLION)
  • TABLE 337 BELGIUM TRANSIENT TRANSFECTION (BY PRODUCT) IN TRANSFECTION MARKET, BY TYPE, 2019-2028 (USD MILLION)
  • TABLE 338 BELGIUM STABLE TRANSFECTION (BY STAGE) IN TRANSFECTION MARKET, BY TYPE, 2019-2028 (USD MILLION)
  • TABLE 339 BELGIUM STABLE TRANSFECTION (BY PRODUCT) IN TRANSFECTION MARKET, BY TYPE, 2019-2028 (USD MILLION)
  • TABLE 340 BELGIUM TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 341 BELGIUM NON-VIRAL METHODS IN TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 342 BELGIUM CHEMICAL IN TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 343 BELGIUM PHYSICAL IN TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 344 BELGIUM VIRAL METHODS IN TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 345 BELGIUM CRISPR TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 346 BELGIUM NON-VIRAL METHODS IN CRISPR TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 347 BELGIUM CHEMICAL IN CRISPR TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 348 BELGIUM PHYSICAL IN CRISPR TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 349 BELGIUM VIRAL METHODS IN CRISPR TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 350 BELGIUM TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 351 BELGIUM REAGENTS & KITS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 352 BELGIUM CATIONIC LIPIDS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 353 BELGIUM LIPOSOMAL REAGENTS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 354 BELGIUM NON-LIPOSOMAL REAGENTS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 355 BELGIUM CATIONIC POLYMER IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 356 BELGIUM KITS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 357 BELGIUM NANOPARTICLES IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 358 BELGIUM INSTRUMENTS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 359 BELGIUM INSTRUMENTS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (UNITS)
  • TABLE 360 BELGIUM ELECTROPORATION SYSTEM IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 361 BELGIUM TRANSFECTION MARKET, BY ORGANISM, 2019-2028 (USD MILLION)
  • TABLE 362 BELGIUM TRANSFECTION MARKET, BY TYPES OF MOLECULE, 2019-2028 (USD MILLION)
  • TABLE 363 BELGIUM TRANSFECTION MARKET (BY TYPE), BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 364 BELGIUM IN VITRO APPLICATION IN TRANSFECTION MARKET (BY TYPE), BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 365 BELGIUM IN VIVO APPLICATION IN TRANSFECTION MARKET (BY TYPE), BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 366 BELGIUM BIOPRODUCTION IN TRANSFECTION MARKET (BY TYPE), BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 367 BELGIUM TRANSFECTION MARKET (BY INDUSTRY), BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 368 BELGIUM SYNTHETIC BIOLOGY IN TRANSFECTION MARKET (BY INDUSTRY), BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 369 BELGIUM TRANSFECTION MARKET, BY STAGE, 2019-2028 (USD MILLION)
  • TABLE 370 BELGIUM TRANSFECTION MARKET, BY END USER, 2019-2028 (USD MILLION)
  • TABLE 371 BELGIUM TRANSFECTION MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
  • TABLE 372 TURKEY TRANSFECTION MARKET, BY TYPE, 2019-2028 (USD MILLION)
  • TABLE 373 TURKEY TRANSIENT TRANSFECTION (BY STAGE) IN TRANSFECTION MARKET, BY TYPE, 2019-2028 (USD MILLION)
  • TABLE 374 TURKEY TRANSIENT TRANSFECTION (BY PRODUCT) IN TRANSFECTION MARKET, BY TYPE, 2019-2028 (USD MILLION)
  • TABLE 375 TURKEY STABLE TRANSFECTION (BY STAGE) IN TRANSFECTION MARKET, BY TYPE, 2019-2028 (USD MILLION)
  • TABLE 376 TURKEY STABLE TRANSFECTION (BY PRODUCT) IN TRANSFECTION MARKET, BY TYPE, 2019-2028 (USD MILLION)
  • TABLE 377 TURKEY TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 378 TURKEY NON-VIRAL METHODS IN TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 379 TURKEY CHEMICAL IN TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 380 TURKEY PHYSICAL IN TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 381 TURKEY VIRAL METHODS IN TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 382 TURKEY CRISPR TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 383 TURKEY NON-VIRAL METHODS IN CRISPR TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 384 TURKEY CHEMICAL IN CRISPR TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 385 TURKEY PHYSICAL IN CRISPR TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 386 TURKEY VIRAL METHODS IN CRISPR TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 387 TURKEY TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 388 TURKEY REAGENTS & KITS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 389 TURKEY CATIONIC LIPIDS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 390 TURKEY LIPOSOMAL REAGENTS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 391 TURKEY NON-LIPOSOMAL REAGENTS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 392 TURKEY CATIONIC POLYMER IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 393 TURKEY KITS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 394 TURKEY NANOPARTICLES IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 395 TURKEY INSTRUMENTS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 396 TURKEY INSTRUMENTS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (UNITS)
  • TABLE 397 TURKEY ELECTROPORATION SYSTEM IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 398 TURKEY TRANSFECTION MARKET, BY ORGANISM, 2019-2028 (USD MILLION)
  • TABLE 399 TURKEY TRANSFECTION MARKET, BY TYPES OF MOLECULE, 2019-2028 (USD MILLION)
  • TABLE 400 TURKEY TRANSFECTION MARKET (BY TYPE), BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 401 TURKEY IN VITRO APPLICATION IN TRANSFECTION MARKET (BY TYPE), BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 402 TURKEY IN VIVO APPLICATION IN TRANSFECTION MARKET (BY TYPE), BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 403 TURKEY BIOPRODUCTION IN TRANSFECTION MARKET (BY TYPE), BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 404 TURKEY TRANSFECTION MARKET (BY INDUSTRY), BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 405 TURKEY SYNTHETIC BIOLOGY IN TRANSFECTION MARKET (BY INDUSTRY), BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 406 TURKEY TRANSFECTION MARKET, BY STAGE, 2019-2028 (USD MILLION)
  • TABLE 407 TURKEY TRANSFECTION MARKET, BY END USER, 2019-2028 (USD MILLION)
  • TABLE 408 TURKEY TRANSFECTION MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
  • TABLE 409 REST OF EUROPE TRANSFECTION MARKET, BY TYPE, 2019-2028 (USD MILLION)

LIST OF FIGURES

  • FIGURE 1 EUROPE TRANSFECTION MARKET: SEGMENTATION
  • FIGURE 2 EUROPE TRANSFECTION MARKET : DATA TRIANGULATION
  • FIGURE 3 EUROPE TRANSFECTION MARKET: DROC ANALYSIS
  • FIGURE 4 EUROPE TRANSFECTION MARKET: EUROPE VS REGIONAL MARKET ANALYSIS
  • FIGURE 5 EUROPE TRANSFECTION MARKET: COMPANY RESEARCH ANALYSIS
  • FIGURE 6 EUROPE TRANSFECTION MARKET: MULTIVARIATE MODELLING
  • FIGURE 7 EUROPE TRANSFECTION MARKET: INTERVIEW DEMOGRAPHICS
  • FIGURE 8 EUROPE TRANSFECTION MARKET: DBMR MARKET POSITION GRID
  • FIGURE 9 EUROPE TRANSFECTION MARKET: MARKET APPLICATION COVERAGE GRID
  • FIGURE 10 EUROPE TRANSFECTION MARKET: VENDOR SHARE ANALYSIS
  • FIGURE 11 EUROPE TRANSFECTION MARKET: SEGMENTATION
  • FIGURE 12 INCREASING OCCURENCE OF CHRONIC DISEASES AND DEVELOPMENT OF SYNTHETIC BIOLOGY PRODUCTS IS DRIVING THE EUROPE TRANSFECTION MARKET IN THE FORECAST PERIOD OF 2021 TO 2028
  • FIGURE 13 TRANSIENT TRANSFECTION SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE EUROPE TRANSFECTION MARKET IN 2021 & 2028
  • FIGURE 14 APPROVAL PROCESS FOR GENE THERAPY IN CHINA
  • FIGURE 15 DRIVERS, RESTRAINTS, OPPORTUNITIES AND CHALLENGES OF EUROPE TRANSFECTION MARKET
  • FIGURE 16 EUROPE TRANSFECTION MARKET: BY TYPE, 2020
  • FIGURE 17 EUROPE TRANSFECTION MARKET: BY TYPE, 2020-2028 (USD MILLION)
  • FIGURE 18 EUROPE TRANSFECTION MARKET: BY TYPE, CAGR (2021-2028)
  • FIGURE 19 EUROPE TRANSFECTION MARKET: BY TYPE, LIFELINE CURVE
  • FIGURE 20 EUROPE TRANSFECTION MARKET: BY METHODS, 2020
  • FIGURE 21 EUROPE TRANSFECTION MARKET: BY METHODS, 2020-2028 (USD MILLION)
  • FIGURE 22 EUROPE TRANSFECTION MARKET: BY METHODS, CAGR (2021-2028)
  • FIGURE 23 EUROPE TRANSFECTION MARKET: BY METHODS, LIFELINE CURVE
  • FIGURE 24 EUROPE TRANSFECTION MARKET: BY METHODS, 2020
  • FIGURE 25 EUROPE TRANSFECTION MARKET: BY METHODS, 2020-2028 (USD MILLION)
  • FIGURE 26 EUROPE TRANSFECTION MARKET: BY METHODS, CAGR (2021-2028)
  • FIGURE 27 EUROPE TRANSFECTION MARKET: BY METHODS, LIFELINE CURVE
  • FIGURE 28 EUROPE TRANSFECTION MARKET: BY PRODUCT, 2020
  • FIGURE 29 EUROPE TRANSFECTION MARKET: BY PRODUCT, 2020-2028 (USD MILLION)
  • FIGURE 30 EUROPE TRANSFECTION MARKET: BY PRODUCT, CAGR (2021-2028)
  • FIGURE 31 EUROPE TRANSFECTION MARKET: BY PRODUCT, LIFELINE CURVE
  • FIGURE 32 EUROPE TRANSFECTION MARKET: BY ORGANISM, 2020
  • FIGURE 33 EUROPE TRANSFECTION MARKET: BY ORGANISM, 2020-2028 (USD MILLION)
  • FIGURE 34 EUROPE TRANSFECTION MARKET: BY ORGANISM, CAGR (2021-2028)
  • FIGURE 35 EUROPE TRANSFECTION MARKET: BY ORGANISM, LIFELINE CURVE
  • FIGURE 36 EUROPE TRANSFECTION MARKET: BY TYPES OF MOLECULE, 2020
  • FIGURE 37 EUROPE TRANSFECTION MARKET: BY TYPES OF MOLECULE, 2020-2028 (USD MILLION)
  • FIGURE 38 EUROPE TRANSFECTION MARKET: BY TYPES OF MOLECULE, CAGR (2021-2028)
  • FIGURE 39 EUROPE TRANSFECTION MARKET: BY TYPES OF MOLECULE LIFELINE CURVE
  • FIGURE 40 EUROPE TRANSFECTION MARKET: BY APPLICATION, 2020
  • FIGURE 41 EUROPE TRANSFECTION MARKET: BY APPLICATION, 2020-2028 (USD MILLION)
  • FIGURE 42 EUROPE TRANSFECTION MARKET: BY APPLICATION, CAGR (2021-2028)
  • FIGURE 43 EUROPE TRANSFECTION MARKET: BY APPLICATION, LIFELINE CURVE
  • FIGURE 44 EUROPE TRANSFECTION MARKET: BY STAGES, 2020
  • FIGURE 45 EUROPE TRANSFECTION MARKET: BY STAGES, 2020-2028 (USD MILLION)
  • FIGURE 46 EUROPE TRANSFECTION MARKET: BY STAGES, CAGR (2021-2028)
  • FIGURE 47 EUROPE TRANSFECTION MARKET: BY STAGES, LIFELINE CURVE
  • FIGURE 48 EUROPE TRANSFECTION MARKET: BY END USER, 2020
  • FIGURE 49 EUROPE TRANSFECTION MARKET: BY END USER, 2020-2028 (USD MILLION)
  • FIGURE 50 EUROPE TRANSFECTION MARKET: BY END USER, CAGR (2021-2028)
  • FIGURE 51 EUROPE TRANSFECTION MARKET: BY END USER, LIFELINE CURVE
  • FIGURE 52 EUROPE TRANSFECTION MARKET: BY DISTRIBUTION CHANNEL, 2020
  • FIGURE 53 EUROPE TRANSFECTION MARKET: BY DISTRIBUTION CHANNEL, 2020-2028 (USD MILLION)
  • FIGURE 54 EUROPE TRANSFECTION MARKET: BY DISTRIBUTION CHANNEL, CAGR (2021-2028)
  • FIGURE 55 EUROPE TRANSFECTION MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE